1-4 of 4
Ming-Hui Tai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Patient Characteristics and Treatment Outcomes Among Newly Diagnosed Multiple Myeloma Patients Initiating Daratumumab, Lenalidomide, and Dexamethasone As First-Line Therapy

Ming-Hui Tai, Qian Cai, Alex Z. Fu, Vipin Khare, Shuchita Kaila
Journal: Blood
Blood (2021) 138 (Supplement 1): 1979.
https://doi.org/10.1182/blood-2021-149002
Published: 2021
Journal Articles

Patient Characteristics, Treatment Patterns and Outcomes Among Black and White Patients with Multiple Myeloma Initiating Daratumumab: A Real-World Chart Review Study

Shebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, Shuchita Kaila, Kathleen Gray, Isabelle Ghelerter, Marie-Hélène Lafeuille, Patrick Lefebvre, Adriana C Rossi
Journal: Blood
Blood (2021) 138 (Supplement 1): 1965.
https://doi.org/10.1182/blood-2021-145941
Published: 2021
Journal Articles

Use of Anti-Infective Prophylaxis in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Initiating Treatment with Daratumumab

Ming-Hui Tai, PhD, Eric M. Ammann, PhD, Shuchita Kaila, PhD, Christopher Pericone, Ajaybir Singh, Thomas S. Lin, MD PhD, Faith E. Davies
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-134086
Published: 2020
Journal Articles

Early Molecular Response (EMR) with Frontline Treatment Is a Significant Predictor of Long-Term BCR-ABL Transcript Levels in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML) in Chronic Phase

Giuseppe Saglio, Sonya J. Snedecor, PhD, Xiang Ji, Ming-Hui Tai, BPharm, MHPA, PhD, David Ray, PharmD, MBA, Estella Mendelson, BSRN, MBA, Aby Buchbinder, Pascal Edrich, Francois-Xavier Mahon, MD PhD Professor
Journal: Blood
Blood (2015) 126 (23): 1579.
https://doi.org/10.1182/blood.V126.23.1579.1579
Published: 2015